Harrow Health (HROW) Stock Statistics & Valuation Metrics

Harrow Health has a market cap or net worth of $1.43B. The enterprise value is $1.36B.

Harrow Health has 37,002,136 shares outstanding. The number of shares has decreased by -2.65% in one year.

Harrow Health’s return on equity (ROE) is -0.25 and return on invested capital (ROIC) is 2.99%.

The current PE Ratio of Harrow Health is ―. Harrow Health’s PEG ratio is ―.

In the last 12 months, Harrow Health had revenue of 199.61M and earned -17.48M in profits. Earnings per share was -0.49.

In the last 12 months, operating cash flow was 4.04M and capital expenditures -38.42M, giving a free cash flow of -34.38M billion.

Harrow Health pays an annual dividend of ―, resulting in a dividend yield of ―

Harrow Health upcoming earnings date is Nov 17, 2025, After Close (Confirmed).

Harrow Health as a current ratio of 2.08, with Debt / Equity ratio of 465.72%

In the past 12 months, Harrow Health has paid 161.00K in taxes.

Harrow Health EV to EBITDA ratio is 71.45, with an EV/FCF ratio of -22.63.

Harrow Health has $52.96M in cash and marketable securities with $231.25M in debt, giving a net cash position of $178.29M billion.

Gross margin is 74.56%, with operating margin of 4.42%, and net profit margin of -8.76%.

The average price target for Harrow Health is $56.80, which is 11.43% higher than the current price. The consensus rating is Strong Buy